Research briefings

AI for science

Genomic AI: the next challenge is trustworthy validation

External research on genomic models, with an independent editorial agenda for regional validation.

The finding

Evo 2 is a DNA foundation model trained on nine trillion base pairs. Its authors report predictions of genetic variant effects without task-specific fine-tuning, alongside other capabilities. The released model and resources invite independent evaluation; predictive performance does not establish clinical usefulness. [1]

Evidence in context

AlphaGenome predicts functional genomic measurements from long DNA sequences, including signals related to gene expression and splicing. Its evaluation concerns particular biological prediction tasks, offering a different route from a broadly trained sequence model. The two papers should not be treated as interchangeable benchmarks. [2]

An independent benchmark of five earlier DNA models found that performance varied across tasks and datasets. General models were competitive on some variant classifications but weaker than specialized approaches on other functional tasks. That study did not evaluate Evo 2 and cannot rank it. [3]

Editorial perspective: what should count as progress?

The following analysis proposes research priorities; it does not report additional findings from these papers. A useful regional programme would begin with a biological question and a decision that better prediction could improve. For example, a university consortium might ask whether a model helps prioritize already documented plant variants for subsequent study. Success should mean more than a higher average benchmark score: the team should specify acceptable uncertainty, the cost of false leads, and whether a simpler method reaches the same conclusion. Public reporting should distinguish a computational hypothesis, an independently replicated association, and an experimentally supported explanation. Each deserves a different level of confidence.

Editorial scrutiny: a validation contract

Before comparing tools, investigators should publish a validation contract: the intended task, reference measurements, excluded datasets, analysis code, and conditions under which they would reject the model. A credible comparison would reserve an untouched evaluation set and document any overlap with training resources. Error analysis should examine individual categories rather than conceal weak performance inside an aggregate. Reproducibility also needs a record of model version, computing requirements, and uncertainty estimates. These are proposed evaluation requirements, not deficiencies established in any particular paper. They would make disagreements informative: teams could identify whether competing results arise from different data, different biological questions, or different definitions of success.

Editorial questions for Latin America

A Latin American agenda could ask whether predictive rankings remain reliable across locally important crop varieties, environmental conditions, and independently collected datasets. Which research questions actually require a large model, and which can be answered with smaller, affordable tools? Who should decide whether a biological dataset may enter a shared benchmark? Proposed collaborators include plant scientists, computational biologists, statisticians, data stewards, and representatives of communities contributing knowledge or samples. Any use of community-associated information should begin with agreed governance and permitted uses. Local validation would require suitable reference measurements and a realistic account of laboratory capacity; a result obtained elsewhere would be a starting hypothesis, not regional proof.

Editorial research pathway

A manageable first project would compare two or three available methods on one openly documented, non-clinical task. The consortium could preregister its evaluation, publish reusable analysis materials, and invite a second institution to reproduce the results before expanding. A final report should disclose failed comparisons, computational expense, and remaining disagreements as carefully as favorable scores. Training could pair biology students with statistics and computing students around the same dataset. The proposed output would be a reproducible regional benchmark and a clear statement of what it can support. It would not be a diagnostic service, a promise of immediate application, or a claim that LAANSSS conducted the underlying studies.

Research sources

  1. Brixi, Durrant, Ku et al. — Genome modelling and design across all domains of life with Evo 2 (Nature, 4 March 2026)
  2. Avsec, Latysheva, Cheng et al. — Advancing regulatory variant effect prediction with AlphaGenome (Nature, 28 January 2026)
  3. Feng, Wu, Zhao et al. — Benchmarking DNA foundation models for genomic and genetic tasks (Nature Communications, 28 November 2025)
Editorial note

This original summary describes research by the credited external authors. LAANSSS is not presented as an author, collaborator or reviewer of the paper. The primary publication remains the authoritative account of the methods and findings.